The group's principal activity is to develop, manufacture and market point-of-care rapid diagnostics for detection of human medical conditions and illness. the products of the group diagnose acute and chronic conditions focused on women's and family health. the products include quickvue, quickvue+, quickvue advance, ovuquick, conceive, cards, rapidvue, bluetest, metra, pyrilinks qus-2, alkphase-b, novocalcin, chondrex, rapignost, rapimat and femexam. these products are sold to professionals for use in the physician's office and clinical laboratories through a network of national and regional distributors and through organizations that provide store brand products. the major customers of the group include allegiance healthcare corporation and mckesson corporation.